Boston Scientific buys medical devices maker EMcision
With operations in the UK and Canada, EMcision is engaged in the development of medical devices based on radiofrequency (RF) technology for the surgical community. EMcision produces Habib
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XWith operations in the UK and Canada, EMcision is engaged in the development of medical devices based on radiofrequency (RF) technology for the surgical community. EMcision produces Habib
The Pyrochrome reagent can perform kinetic or endpoint assays featuring a maximum sensitivity of 0.001 EU/ml, an option to use polynomial regression with a sample to lysate volume